Home Journals Articles Updates About
CN
image
收藏切换
Current status of treatment and drug discovery for epilepsy
收藏切换
PDF
Ying LIU1, 2, Hai-bo YU2, *, Qing-fei KONG1, *
Acta Pharmaceutica Sinica | 2021, 56(4) : 924 - 938
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(4): 924-938
• Reviews •
Current status of treatment and drug discovery for epilepsy
Full
Ying LIU1, 2, Hai-bo YU2, *, Qing-fei KONG1, *
Affiliations
  • 1. Department of Neurobiology, Harbin Medical University, Harbin 150086, China
  • 2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2021-04-12 doi: 10.16438/j.0513-4870.2020-1578
Outline
收藏切换

Epilepsy is one of the most common neurological conditions, which is characterized by recurrent unprovoked seizures. Drug treatment is still the main method for the disease. Although remarkable progress has been made in the development of antiepileptic drugs in recent years, there is still a poor curative effect on patients with refractory epilepsy. This review will focus on the current status and pathogenesis of epilepsy, as well as the antiepileptic drugs (targeting sodium channels, calcium channels, potassium channels, and the balance of γ-aminobuyric acid/glutamate system, respectively) that have been developed based on classical epileptogenic mechanisms. Further the antiepileptic drugs acting on new targets (epigenetic interferers, synaptic vesicle glycoprotein 2A modulators, mammalian target of rapamycin signal pathway blockers, carbonic anhydrase inhibitors, cannabidiol and adenosine inhibitors) have also been discussed.

epilepsy  /  antiepileptic drug  /  drug resistant epilepsy  /  ion channel  /  G-protein coupled receptor
Ying LIU, Hai-bo YU, Qing-fei KONG. Current status of treatment and drug discovery for epilepsy[J]. Acta Pharmaceutica Sinica, 2021 , 56 (4) : 924 -938 . DOI: 10.16438/j.0513-4870.2020-1578
Appendix
Less
Year 2021 volume 56 Issue 4
PDF
196
89
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-1578
  • Receive Date：2020-10-08
  • Online Date：2025-12-18
  • Published：2021-04-12
Article Data
Affiliations
History
  • Received：2020-10-08
  • Revised：2020-12-01
Funding
Affiliations
    1. Department of Neurobiology, Harbin Medical University, Harbin 150086, China
    2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-1578
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House